Profile data is unavailable for this security.
About the company
Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.
- Revenue in INR (TTM)3.82bn
- Net income in INR435.24m
- Incorporated1969
- Employees996.00
- LocationThemis Medicare Ltd11/12 Udyog Nagar, S V Road, Goregaon (West)MUMBAI 400104IndiaIND
- Phone+91 2 267607080
- Fax+91 2 228746621
- Websitehttps://www.themismedicare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta Drugs Ltd | 2.56bn | 347.57m | 11.56bn | 315.00 | 33.25 | 8.14 | 25.25 | 4.52 | 36.15 | 36.15 | 266.28 | 147.68 | 1.24 | 4.44 | 3.72 | 8,126,721.00 | 16.85 | -- | 25.36 | -- | 41.88 | -- | 13.58 | -- | 1.43 | 18.21 | 0.098 | -- | 23.54 | -- | 23.73 | -- | -- | -- |
Zota Health Care Ltd | 1.80bn | -143.48m | 12.32bn | 338.00 | -- | 13.34 | 214.44 | 6.82 | -5.59 | -5.59 | 70.40 | 34.81 | 0.9341 | 2.02 | 6.55 | -- | -7.42 | -1.38 | -10.54 | -1.85 | 46.43 | 36.48 | -7.95 | -1.33 | 0.7851 | -2.62 | 0.5143 | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
Windlas Biotech Ltd | 6.31bn | 581.87m | 13.15bn | 1.05k | 22.62 | 2.92 | 18.35 | 2.08 | 27.94 | 27.94 | 302.99 | 216.33 | 1.09 | 5.79 | 4.99 | -- | 10.07 | -- | 13.50 | -- | 37.21 | -- | 9.22 | -- | 2.15 | 58.58 | 0.008 | -- | 22.97 | -- | 36.51 | -- | -- | -- |
Ngl Fine Chem Ltd | 3.39bn | 413.43m | 13.85bn | 343.00 | 33.50 | 5.27 | 26.15 | 4.09 | 66.92 | 66.92 | 548.61 | 425.11 | 1.05 | 4.51 | 4.36 | -- | 12.87 | 15.06 | 16.61 | 19.58 | 53.18 | 46.79 | 12.20 | 13.15 | 1.96 | 30.64 | 0.1218 | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
Hester Biosciences Ltd | 3.05bn | 188.89m | 15.30bn | 693.00 | 72.26 | 5.24 | 39.91 | 5.02 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
SMS Pharmaceuticals Ltd | 7.09bn | 498.26m | 16.77bn | 1.10k | 33.63 | 3.13 | 20.78 | 2.36 | 5.89 | 5.89 | 83.84 | 63.36 | 0.7413 | 2.18 | 3.69 | -- | 5.14 | 5.43 | 7.41 | 7.33 | 29.83 | 32.67 | 6.94 | 7.87 | 0.905 | 3.63 | 0.3436 | 6.59 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
Themis Medicare Ltd | 3.82bn | 435.24m | 18.66bn | 996.00 | 42.95 | 4.94 | 33.46 | 4.89 | 4.72 | 4.72 | 41.41 | 41.03 | 0.7067 | 1.96 | 2.36 | -- | 8.06 | 11.12 | 11.07 | 16.46 | 64.19 | 61.49 | 11.40 | 14.96 | 1.44 | -- | 0.2023 | 8.28 | 7.74 | 15.75 | -23.51 | -- | 26.73 | -- |
Amrutanjan Health Care Ltd | 4.21bn | 449.73m | 19.98bn | 575.00 | 44.58 | 6.93 | 39.15 | 4.74 | 15.51 | 15.51 | 145.00 | 99.85 | 1.16 | 7.34 | 10.41 | -- | 12.34 | 16.22 | 15.09 | 20.12 | 49.71 | 53.30 | 10.68 | 13.23 | 3.82 | 291.99 | 0.006 | 23.37 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
Solara Active Pharma Sciences Ltd | 13.26bn | -5.67bn | 20.07bn | 2.36k | -- | 1.75 | -- | 1.51 | -145.25 | -145.25 | 339.41 | 239.08 | 0.505 | 1.75 | 2.99 | -- | -21.60 | -2.44 | -39.08 | -3.84 | 39.28 | 43.38 | -42.77 | -4.49 | 0.3549 | -1.89 | 0.5192 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
Suven Life Sciences Ltd | 116.93m | -1.05bn | 20.19bn | 132.00 | -- | 7.48 | -- | 172.70 | -4.82 | -4.82 | 0.5359 | 12.38 | 0.0347 | -- | 11.17 | -- | -31.19 | -46.46 | -32.37 | -50.52 | -- | -- | -898.63 | -787.61 | 18.94 | -849.16 | 0.0026 | -- | -13.64 | -47.23 | 11.15 | -- | -- | -- |
RPG Life Sciences Limited | 5.82bn | 876.60m | 23.62bn | 1.17k | 26.95 | 6.30 | 22.56 | 4.06 | 53.01 | 53.01 | 351.99 | 226.65 | 1.25 | 1.88 | 13.45 | -- | 18.81 | 16.07 | 25.10 | 21.77 | 68.30 | 64.04 | 15.06 | 11.99 | 1.50 | 246.84 | 0.00 | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
Morepen Laboratories Ltd | 16.90bn | 961.60m | 23.64bn | 1.65k | 24.60 | 2.79 | 18.17 | 1.40 | 1.88 | 1.88 | 33.11 | 16.58 | 1.41 | 4.45 | 5.74 | -- | 8.04 | 7.90 | 11.50 | 13.34 | 37.15 | 33.65 | 5.72 | 5.49 | 1.59 | 33.73 | 0.0331 | -- | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
Dishman Carbogen Amcis Ltd | 25.80bn | -1.54bn | 25.20bn | 1.30k | -- | -- | 17.10 | 0.9767 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
SeQuent Scientific Ltd | 13.70bn | -358.69m | 25.77bn | 478.00 | -- | 3.92 | 80.70 | 1.88 | -1.45 | -1.45 | 56.27 | 26.37 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
Holder | Shares | % Held |
---|---|---|
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 2024 | 396.00 | 0.00% |